Some researchers are still trying to convince us that CV-19 vax is worth getting year-after-year-after-year. As I never tire of pointing out, the studies on effectiveness, which are used to justify the endless receipt of these vaccines, are fatally flawed from a total inability to sort out the effect of ongoing multiple CV-19 infections in just about every single American. The latest is a study from the VA allegedly assessing the 2024/25 version of the vaccine. Those who received the CV-19 and flu vax at the same time were compared to those who only got the flu one. Supposedly after 6 months the double-vaxed group had a 29% lower chance of having an ER visit for CV-19, a 39% lower chance of a hospitalization, and a 64% lower risk of a CV-19 death. Confidence intervals were extremely wide, showing how poor the association was. The effect was almost exclusively seen in older adults. The effectiveness showed the usual waning in a relatively short period of time. (NEJM Study)
Oh, and I should have mentioned, two of the researchers are Pfizer consultants.
